Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 22, 2022

SELL
$2.94 - $11.87 $14,755 - $59,575
-5,019 Closed
0 $0
Q1 2022

Jun 07, 2022

SELL
$4.38 - $18.78 $39,420 - $169,020
-9,000 Reduced 64.2%
5,019 $25,000
Q3 2021

Nov 10, 2021

BUY
$29.44 - $43.74 $412,719 - $613,191
14,019 New
14,019 $413,000
Q1 2021

May 19, 2021

SELL
$32.41 - $70.91 $97,229 - $212,730
-3,000 Closed
0 $0
Q4 2020

Mar 08, 2021

BUY
$31.02 - $35.16 $93,060 - $105,479
3,000 New
3,000 $102,000

Others Institutions Holding BCAB

About BioAtla, Inc.


  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $62.4M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.